SEARCH RESULTS for assignee:"merck sharp dohme corp"

Showing 1 to 20 of 278 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15774622: CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

(A1) 20180339017: CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15775487: BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS

(A1) 20180339983: BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS

Reel/Frame

Last Update:

Patent(s)

(X0) 15774622: CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

(A1) 20180339017: CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15525788: AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

(A1) 20180327385: AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

Reel/Frame

Last Update:

Patent(s)

(X0) 15777244: METERING INJECTOR FOR DELIVERNG LIQUID, AND METHOD OF USING SAME

(A1) 20180326157: METERING INJECTOR FOR DELIVERNG LIQUID, AND METHOD OF USING SAME

Reel/Frame

Last Update:

Patent(s)

(X0) 15533769: SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPONSE TO PD-1 ANTAGONISTS

(A1) 20180327848: SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPONSE TO PD-1 ANTAGONISTS

Reel/Frame

Last Update:

Patent(s)

(X0) 15525788: AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

(A1) 20180327385: AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

Reel/Frame

Last Update:

Patent(s)

(X0) 15775871: Spirocyclic Pyridotriazine Derivatives Useful As HIV Integrase Inhibitors

(A1) 20180325926: Spirocyclic Pyridotriazine Derivatives Useful As HIV Integrase Inhibitors

Reel/Frame

Last Update:

Patent(s)

(X0) 15775966: Amido-Substituted Pyridotriazine Derivatives Useful As HIV Integrase Inhibitors

(A1) 20180325927: Amido-Substituted Pyridotriazine Derivatives Useful As HIV Integrase Inhibitors

Reel/Frame

Last Update:

Patent(s)

(X0) 16032715: NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

(A1) 20180319804: NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15966602: PHARMACEUTICAL FORMULATIONS COMPRISING INSULIN OR INSULIN ANALOGS CONJUGATED TO FUCOSE

(A1) 20180318427: PHARMACEUTICAL FORMULATIONS COMPRISING INSULIN OR INSULIN ANALOGS CONJUGATED TO FUCOSE

Reel/Frame

Last Update:

Patent(s)

(X0) 15966585: PHARMACEUTICAL FORMULATIONS COMPRISING INSULIN OR INSULIN ANALOGS CONJUGATED TO FUCOSE FOR PROVIDING A BASAL PHARMACODYNAMIC PROFILE

(A1) 20180318426: PHARMACEUTICAL FORMULATIONS COMPRISING INSULIN OR INSULIN ANALOGS CONJUGATED TO FUCOSE FOR PROVIDING A BASAL PHARMACODYNAMIC PROFILE

Reel/Frame

Last Update:

Patent(s)

(X0) 15115026: TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

(A1) 20160346214: TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

(B2) 1: TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

Reel/Frame

Last Update:

Patent(s)

(X0) 15115026: TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

(A1) 20160346214: TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

(B2) 1: TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

Reel/Frame

Last Update:

Patent(s)

(X0) 15587934: TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE

(A1) 20170313722: TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE

Reel/Frame

Last Update:

Patent(s)

(X0) 15749934: METHODS FOR MAKING PHARMACEUTICAL SOLID DOSAGE FORMS OF SPRAY-DRIED DISPERSIONS

(A1) 20180221282: METHODS FOR MAKING PHARMACEUTICAL SOLID DOSAGE FORMS OF SPRAY-DRIED DISPERSIONS

Reel/Frame

Last Update:

Patent(s)

(X0) 15749934: METHODS FOR MAKING PHARMACEUTICAL SOLID DOSAGE FORMS OF SPRAY-DRIED DISPERSIONS

(A1) 20180221282: METHODS FOR MAKING PHARMACEUTICAL SOLID DOSAGE FORMS OF SPRAY-DRIED DISPERSIONS

Reel/Frame

Last Update:

Patent(s)

(X0) 16019964: SOLUBLE GUANYLATE CYCLASE STIMULATORS

(A1) 20180305366: SOLUBLE GUANYLATE CYCLASE STIMULATORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15767371: ARYL ACYLSULFONAMIDES AS BLT1 ANTAGONISTS

(A1) 20180305342: ARYL ACYLSULFONAMIDES AS BLT1 ANTAGONISTS